Alice Park is senior health correspondent at TIME and author of “The Stem Cell Hope: How Stem Cell Medicine Can Change Our Lives.” In 2019, she co-chaired the inaugural Time 100 Health Summit. Park’s cover stories have addressed stem cells, childhood vaccinations, the health care system, heart disease, HIV, cancer immunotherapy, and the gene editing technology CRISPR. She contributed to TIME’s coverage of the COVID-19 pandemic, focusing on the race to develop effective vaccines. Park also contributes to the magazine’s Olympics coverage, covering figure skating, gymnastics and swimming. She is the recipient of the 2021 New York Press Club Award for Feature Reporting—Science, Medicine & Technology for her story “How Remdesivir Moved From Back Shelf to Best Hope for Treating COVID-19” and has appeared on CNN, BBC America, NPR and “Good Morning America.”
Previously
The 3M’s—Medicare, Medicaid and the Children’s Health Insurance Program, and the Affordable Care Act Marketplaces—cover more than 160 million people across the country, nearly...
The idea of gathering DNA samples into a vast database in order to identify disease risks and breakthrough therapies was once a distant dream. Not long ago, immunotherapy seem...
Barely a dozen years ago, Jennifer Doudna and her colleagues published a paper in Science about CRISPR, the pioneering gene-editing technique that thrilled the scientific comm...